论文部分内容阅读
目的:比较分析常规静脉滴注与山莨菪碱或盐酸氨溴索2种辅助疗法对支气管肺炎的临床治疗效果。方法:我院2012年2月~2012年12月收住的支气管肺炎患者120例,随机分为2组,各60例,第1组给予常规静脉滴注法+山莨菪碱,第2组给予常规静脉滴注+盐酸氨溴索。观察2组疗效及患者临床症状、体征变化情况。结果:2组患者在总有效率、临床症状以及体征改善方面,均有显著性差异(P<0.05)。结论:常规静脉滴注+盐酸氨溴索治疗支气管肺炎的疗效明显优于常规静脉滴注+山莨菪碱,并减少住院时间,节省诊疗费用,减轻患儿痛苦,应推广应用。
OBJECTIVE: To compare the clinical effects of routine intravenous drip with anisodamine or ambroxol hydrochloride on bronchopneumonia. Methods: 120 cases of bronchial pneumonia admitted from February 2012 to December 2012 in our hospital were randomly divided into 2 groups (60 cases each). The first group received conventional intravenous drip + anisodamine and the second group received Conventional intravenous infusion of ambroxol hydrochloride. The curative effect and clinical symptoms and signs of 2 groups were observed. Results: The two groups of patients in the total effective rate, clinical symptoms and signs of improvement, there was a significant difference (P <0.05). Conclusion: Conventional intravenous infusion of ambroxol hydrochloride in the treatment of bronchial pneumonia is superior to conventional intravenous infusion of anisodamine and reduce the length of stay, saving treatment costs, reduce the suffering of children, should be widely applied.